Press Releases Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel Go Year All Years 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 Keywords Go Advanced Search Search Search Headlines Only From To Asset Types Photos Video Audio Documents Events Standard Nov 14, 2023 Evofem Biosciences Announces Financial Results for the Third Quarter of 2023 Oct 24, 2023 Evofem Biosciences Announces Preliminary Results for the Third Quarter of 2023 Oct 13, 2023 Evofem to Participate in the Virtual Investor Ask the CEO Conference Sep 27, 2023 Evofem Announces Padagis Will Not Seek FDA Approval to Market a Generic Version of Phexxi® Until Evofem's Phexxi Patents Expire Sep 11, 2023 Evofem Biosciences Successfully Amends S.P.A. with Institutional Investor Aug 22, 2023 Evofem Biosciences Signs Non-Binding Letter of Intent to Enable Listing on a National Stock Exchange Aug 14, 2023 Evofem Biosciences Announces Financial Results for the Second Quarter of 2023 Jul 6, 2023 Evofem to Participate in the Virtual Investor Summer Spotlight Series Jun 16, 2023 Evofem Biosciences Announces Financial Results for the First Quarter of 2023 Jun 1, 2023 Evofem Biosciences Announces Strong Preliminary Results for the First Quarter of 2023 Show 5102550100 per page«123456789…24»
